GLOBUS MEDICAL, INC. (GMED) Total liabilities 2016–2025
GLOBUS MEDICAL, INC. (GMED) total liabilities at each fiscal year-end, per SEC filings.
$729.5MFY2025 · since FY2016: $95.6M → $729.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $729.5M | -32.1% |
| FY2024 | $1.1B | -1.3% |
| FY2023 | $1.1B | +373.6% |
| FY2022 | $229.8M | +6.4% |
| FY2021 | $215.9M | +24.6% |
| FY2020 | $173.2M | +33.6% |
| FY2019 | $129.6M | +12.6% |
| FY2018 | $115.2M | +4.0% |
| FY2017 | $110.7M | +15.9% |
| FY2016 | $95.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More GMED financial trends
GMED RevenueGMED Net incomeGMED Net marginGMED Gross profitGMED Gross marginGMED Operating incomeGMED Operating marginGMED Operating cash flowGMED Free cash flowGMED Capital expendituresGMED Return on equityGMED Stock buybacksGMED Dividends paidGMED Total assetsGMED Shareholders’ equityGMED overview →